Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DR26FDDQ2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,738
Award facts
- Contract value 100% obligated
- $37,737.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,737.54 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Kalydeco 150 mg tablets (56-count units). The award, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation and was processed without restrictions, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will fulfill this delivery order under its broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract with the Defense Logistics Agency, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V initiative represents a $30.3 billion acquisition strategy designed to support the Department of Defense's recurring pharmaceutical and medical supply needs across military healthcare facilities worldwide. As a prime vendor contractor under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and maintains a comprehensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's established performance across numerous delivery orders positions it as a critical supplier within the federal military medical pharmaceutical supply chain, serving the Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FDDQ2?
SPE2DR26FDDQ2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FDDQ2 worth?
The government has obligated $37,738 on SPE2DR26FDDQ2.
Is contract SPE2DR26FDDQ2 an order under another contract?
Yes. SPE2DR26FDDQ2 is a delivery order under SPE2DR25D9102, an indefinite delivery contract.
Was contract SPE2DR26FDDQ2 competed?
The extent of competition for SPE2DR26FDDQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award